Scholarly Index
Aukje K. Mantel‐Teeuwisse
Utrecht University; 6,415 total citations; 255 total publications; best world rank #25
Utrecht University
6,415Total citations
255Total publications
40H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Pharmaceutical Economics and Policy | Lifetime | 142 | NL 7 | 97.73 |
| Pharmaceutical studies and practices | Lifetime | 352 | NL 24 | 97.25 |
| Biosimilars and Bioanalytical Methods | Lifetime | 201 | NL 23 | 96.38 |
| Pharmaceutical Practices and Patient Outcomes | Lifetime | 715 | NL 29 | 95.54 |
| Pharmacovigilance and Adverse Drug Reactions | Lifetime | 274 | NL 21 | 92.81 |
| Pharmaceutical industry and healthcare | Lifetime | 405 | NL 6 | 88.78 |
| Pharmaceutical Quality and Counterfeiting | Lifetime | 171 | NL 6 | 80.90 |
| Pharmaceutical Economics and Policy | 2021-2025 | 25 | NL 1 | 97.39 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 297 | NL 20 | 97.02 |
| Pharmaceutical studies and practices | 2021-2025 | 74 | NL 9 | 94.40 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 313 | NL 16 | 87.06 |
| Pharmaceutical Quality and Counterfeiting | 2021-2025 | 60 | NL 1 | 76.52 |
| Pharmaceutical industry and healthcare | 2021-2025 | 160 | NL 3 | 69.26 |
| Global Health and Surgery | 2021-2025 | 787 | NL 7 | 62.97 |
| Pharmacovigilance and Adverse Drug Reactions | 2021-2025 | 586 | NL 37 | 61.23 |
| Intellectual Property and Patents | 2021-2025 | 566 | NL 17 | 37.24 |